|
|
Article: Thoughts on anti-addiction drug therapy: the medical director of a leading addiction treatment center offers personal assessments of recent developments.(Cover Story)
- Article from:
- Behavioral Health Management
- Article date:
- November 1, 1995
- Author:
CopyrightCOPYRIGHT 1995 Vendome Group LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Pharmacotherapy for addiction is starting to come into its own. After years of little progress but considerable controversy, new anti-addiction agents are being introduced, and more are on the horizon. Managed care will be called upon to evaluate the cost-effectiveness of these medications, and with this in mind, I would offer some observations. This is not a scientific paper, but rather reflections from long-time experience--one provider's attempt to update behavioral managed care decisionmakers on a field with which they may be relatively unfamiliar. I will address specific agents, as well as philosophies of care.
Naltrexone (ReVIA): Approved by the Food and Drug ...
Related newspaper, magazine, and journal articles:
|
|
Article: Methadone
Gale Encyclopedia of Mental Disorders;
700+ words
...Methadone Definition Methadone is classified as an opioid (an analgesic that is used for severe pain). In the United States, methadone is also known as dolophine, methenex and methadose. Purpose Methadone ...
|
|